Disappointing outcome of bitopertin treatment for negative symptoms in schizophrenia
Two new phase III clinical trials investigating the efficacy and safety of bitopertin, a glycine uptake inhibitor considered to be a promising new add-on therapy for treating negative symptoms in schizophrenia, failed to ...
Jun 14, 2017
0
1